COVID‐19–associated pulmonary aspergillosis: a prospective single‐center dual case series

BACKGROUND: COVID‐19–associated pulmonary aspergillosis (CAPA) has emerged as an invasive fungal disease, often affecting previously immunocompetent, mechanically ventilated, intensive care unit (ICU) patients. Incidence rates of 3.8%–33.3% have been reported depending on the geographic area, with h...

Descripción completa

Detalles Bibliográficos
Autores principales: Meijer, Eelco F. J., Dofferhoff, Anton S. M., Hoiting, Oscar, Meis, Jacques F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986084/
https://www.ncbi.nlm.nih.gov/pubmed/33569857
http://dx.doi.org/10.1111/myc.13254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986084/
https://www.ncbi.nlm.nih.gov/pubmed/33569857
http://dx.doi.org/10.1111/myc.13254

Ejemplares similares